Yifeng Pharmary(603939)

Search documents
益丰药房(603939) - 益丰药房关于公司高级管理人员离任的公告
2025-08-25 09:15
| 证券代码:603939 | 证券简称:益丰药房 | 公告编号:2025-079 | | --- | --- | --- | | 债券代码:113682 | 债券简称:益丰转债 | | 益丰大药房连锁股份有限公司 关于公司高级管理人员离任的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 益丰大药房连锁股份有限公司(以下简称"公司")董事会于近日收到公司副 总裁章佳先生的书面辞职报告。章佳先生因个人原因申请辞去公司副总裁职务, 辞职后不再担任公司其他任何职务。 一、高级管理人员离任情况 (一) 提前离任的基本情况 | 姓名 | 离任职 | | | 原定任期 | 离任 | 是否继续在上 | 具体职务 | 是否存在 未履行完 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 务 | 离任时间 | | 到期日 | 原因 | 市公司及其控 股子公司任职 | (如适 用) | 毕的公开 | | | | | | | | | | 承诺 | | 章 ...
益丰药房(603939) - 益丰药房2025年第二次临时股东会决议公告
2025-08-25 09:15
| 证券代码:603939 | 证券简称:益丰药房 | 公告编号:2025-077 | | --- | --- | --- | | 债券代码:113682 | 债券简称:益丰转债 | | 益丰大药房连锁股份有限公司 2025年第二次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 本次会议是否有否决议案:无 一、 会议召开和出席情况 (一)股东会召开的时间:2025 年 8 月 25 日 (二)股东会召开的地点:湖南省长沙市金洲大道 68 号益丰医药物流园三楼 本次会议采取现场投票和网络投票相结合的方式召开,公司董事会召集本次 会议,董事长高毅先生主持。本次会议的召集、召开和表决方式符合《公司法》 《上海证券交易所股票上市规则》《公司章程》和公司《股东大会议事规则》的 规定,合法有效。 (五)公司董事、监事和董事会秘书的出席情况 1、公司在任董事9人,出席9人; 2、公司在任监事3人,出席3人; 3、董事会秘书范炜出席会议;公司部分其他高管列席本次会议。 二、 议案审议情况 (一)非累积投票议 ...
益丰药房(603939) - 湖南启元律师事务所关于益丰大药房连锁股份有限公司2025年第二次临时股东会的法律意见书
2025-08-25 09:02
关于益丰大药房连锁股份有限公司 2025年第二次临时股东会的 法律意见书 二O二五年八月 致:益丰大药房连锁股份有限公司 湖南启元律师事务所(以下简称"本所")接受益丰大药房连锁股份有限公 司(以下简称"公司")的委托,指派本律师出席了公司 2025 年第二次临时股东 会(以下简称"本次股东会"),对本次股东会的召集和召开程序、出席会议人 员及召集人的资格、表决程序和表决结果的合法有效性进行现场律师见证,并发 表本法律意见。 本律师根据《中华人民共和国公司法》(以下简称"《公司法》")、《中华 人民共和国证券法》、《上市公司股东会规则》(以下简称"《股东会规则》") 等我国现行法律、法规、规范性文件以及《益丰大药房连锁股份有限公司章程》 (以下简称"《公司章程》")的有关规定出具本法律意见书。 本所及经办律师依据《证券法》、《律师事务所从事证券法律业务管理办法》 和《律师事务所证券法律业务执业规则》等规定及本法律意见书出具日以前已经 发生或者存在的事实,严格履行了法定职责,遵循了勤勉尽责和诚实信用原则, 进行了充分的核查验证,保证本法律意见所认定的事实真实、准确、完整,所发 表的结论性意见合法、准确,不存在虚 ...
益丰药房:副总裁章佳因个人原因辞职
Xin Lang Cai Jing· 2025-08-25 08:57
Core Viewpoint - Yifeng Pharmacy announced the resignation of Vice President Zhang Jia due to personal reasons, effective immediately upon delivery of the resignation letter to the board [1] Company Summary - The board of directors received a written resignation report from Vice President Zhang Jia on August 25 [1] - Zhang Jia will not hold any other positions within the company after resigning [1]
医药商业板块8月22日涨0.05%,塞力医疗领涨,主力资金净流入3.63亿元
Zheng Xing Xing Ye Ri Bao· 2025-08-22 08:39
Core Insights - The pharmaceutical commercial sector experienced a slight increase of 0.05% on August 22, with Saily Medical leading the gains [1] - The Shanghai Composite Index closed at 3825.76, up 1.45%, while the Shenzhen Component Index closed at 12166.06, up 2.07% [1] Group 1: Stock Performance - Saily Medical (603716) saw a closing price of 31.52, with a significant increase of 10.02% and a trading volume of 614,300 shares, resulting in a transaction value of 1.861 billion yuan [1] - Guofang Co. (600538) closed at 6.55, up 2.18%, with a trading volume of 218,500 shares [1] - Runda Medical (603108) closed at 18.35, up 1.94%, with a trading volume of 303,900 shares [1] - Other notable stocks include Jiuzhoutong (600998) with a slight increase of 0.55% and Yifeng Pharmacy (603939) with a minimal increase of 0.20% [1] Group 2: Capital Flow - The pharmaceutical commercial sector saw a net inflow of 363 million yuan from main funds, while retail investors experienced a net outflow of 114 million yuan [2] - Speculative funds recorded a net outflow of 249 million yuan [2]
医药商业板块8月21日涨0.27%,国发股份领涨,主力资金净流出2.77亿元
Zheng Xing Xing Ye Ri Bao· 2025-08-21 08:30
Market Overview - The pharmaceutical commercial sector increased by 0.27% on August 21, with Guofang Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 3771.1, up 0.13%, while the Shenzhen Component Index closed at 11919.76, down 0.06% [1] Stock Performance - Guofang Co., Ltd. (600538) closed at 6.41, up 1.91% with a trading volume of 315,600 shares and a transaction value of 202 million yuan [1] - Nanjing Pharmaceutical (600713) closed at 5.39, up 1.70% with a trading volume of 181,000 shares and a transaction value of 96.97 million yuan [1] - Shanghai Pharmaceuticals (601607) closed at 19.20, up 0.95% with a trading volume of 173,600 shares and a transaction value of 333 million yuan [1] - Yifeng Pharmacy (603939) closed at 24.49, up 0.91% with a trading volume of 88,100 shares and a transaction value of 215 million yuan [1] Capital Flow - The pharmaceutical commercial sector experienced a net outflow of 277 million yuan from institutional investors, while retail investors saw a net inflow of 293 million yuan [2] - The data indicates that institutional investors are withdrawing capital, while retail investors are increasing their investments in the sector [2] Individual Stock Capital Flow - Nanjing Pharmaceutical saw a net inflow of 16.81 million yuan from institutional investors, while retail investors had a net outflow of 4.14 million yuan [3] - Yifeng Pharmacy experienced a net inflow of 15.49 million yuan from institutional investors, with a net outflow of 23.62 million yuan from retail investors [3] - China National Pharmaceutical (600056) had a net inflow of 8.93 million yuan from institutional investors, while retail investors had a negligible net inflow of 0.12 million yuan [3]
医药商业板块8月20日涨0.05%,益丰药房领涨,主力资金净流出3.77亿元
Zheng Xing Xing Ye Ri Bao· 2025-08-20 08:41
Market Overview - The pharmaceutical commercial sector increased by 0.05% on August 20, with Yifeng Pharmacy leading the gains [1] - The Shanghai Composite Index closed at 3766.21, up 1.04%, while the Shenzhen Component Index closed at 11926.74, up 0.89% [1] Stock Performance - Yifeng Pharmacy (603939) closed at 24.27, up 0.87% with a trading volume of 58,700 shares and a turnover of 141 million yuan [1] - Other notable performers include: - Liuyuan Group (603368) at 18.64, up 0.76% [1] - China National Pharmaceutical Group (600511) at 30.01, up 0.60% [1] - Shanghai Pharmaceuticals (601607) at 19.02, up 0.58% [1] - Nanjing Pharmaceutical (600713) at 5.30, up 0.57% [1] Capital Flow - The pharmaceutical commercial sector experienced a net outflow of 377 million yuan from institutional investors, while retail investors saw a net inflow of 367 million yuan [2] - Notable capital flows include: - Yifeng Pharmacy had a net outflow of 9.79 million yuan from institutional investors [3] - Heavy Drug Holdings (000950) saw a net inflow of 7.45 million yuan from institutional investors [3] - Drug Easy Purchase (300937) had a net inflow of 3.82 million yuan from institutional investors [3]
益丰药房股价微涨0.8% 自助售药机新规引行业热议
Jin Rong Jie· 2025-08-19 17:48
Company Overview - Yifeng Pharmacy's stock price reached 24.06 yuan as of August 19, 2025, with an increase of 0.19 yuan, representing a 0.8% rise [1] - The trading volume on the same day was 94,200 hands, with a transaction value of 227 million yuan, and a fluctuation of 2.35% [1] - The company operates in the pharmaceutical retail and health management services sector, covering multiple provinces and cities across China [1] Industry Insights - Recent discussions have emerged regarding the management regulations for self-service medicine dispensing machines, with some proposals allowing prescription drug collection through these machines [1] - This potential policy change raises concerns among traditional pharmacies about cost competition and medication safety [1] - Industry experts believe that if these regulations are implemented, they could pose challenges to the operational models of traditional pharmacies [1] Financial Activity - On August 19, 2025, Yifeng Pharmacy experienced a net inflow of 14.72 million yuan in main funds, with a cumulative net inflow of 24.02 million yuan over the past five days [1]
益丰药房(603939) - 益丰药房2025年第二次临时股东会会议资料
2025-08-19 11:46
益丰大药房连锁股份有限公司 2025 年第二次临时股东会会议资料 益丰大药房连锁股份有限公司 2025 年第二次临时股东会 会议资料 2025 年 8 月 1 / 47 益丰大药房连锁股份有限公司 2025 年第二次临时股东会会议资料 | | | | 2025 | 年第二次临时股东会会议议程····························································· | 3 | | --- | --- | --- | | 2025 | 年第二次临时股东会会议须知····························································· | 5 | | 2025 | 年第二次临时股东会会议议案····························································· | 6 | | 议案 | 1:关于取消监事会并修订《公司章程》的议案······································ | 6 | | 议案 | 2:关于修订《董事会议事规则》的议案 ...
益丰药房(603939)8月19日主力资金净流入1472.66万元
Sou Hu Cai Jing· 2025-08-19 08:16
天眼查商业履历信息显示,益丰大药房连锁股份有限公司,成立于2008年,位于常德市,是一家以从事 卫生为主的企业。企业注册资本121243.2297万人民币,实缴资本12000万人民币。公司法定代表人为高 毅。 通过天眼查大数据分析,益丰大药房连锁股份有限公司共对外投资了33家企业,参与招投标项目1315 次,知识产权方面有商标信息311条,专利信息6条,此外企业还拥有行政许可127个。 来源:金融界 金融界消息 截至2025年8月19日收盘,益丰药房(603939)报收于24.06元,上涨0.8%,换手率0.78%, 成交量9.42万手,成交金额2.27亿元。 资金流向方面,今日主力资金净流入1472.66万元,占比成交额6.49%。其中,超大单净流入1146.64万 元、占成交额5.06%,大单净流入326.03万元、占成交额1.44%,中单净流出流出582.78万元、占成交额 2.57%,小单净流出889.88万元、占成交额3.92%。 益丰药房最新一期业绩显示,截至2025一季报,公司营业总收入60.09亿元、同比增长0.64%,归属净利 润4.49亿元,同比增长10.51%,扣非净利润4.38亿元,同 ...